top of page

Asia-Pacific family offices eye China for increased investments


Asia's wealthiest families are gearing up to boost their investments in China following a pullback in 2022 due to stringent Covid-19 restrictions and regulatory curbs, says a UBS Group survey. Approximately 30% of Asia-Pacific family offices anticipate increasing their asset allocation in Greater China over the next five years, contrasting with just 6% planning to avoid the region altogether. These moves follow a reduction in investments in 2022, from 40% to 23% of portfolios. However, UBS reports that the region's strong economic growth remains a magnet for investors, with growing interest also observed in fixed income and equities in developed markets. Meanwhile, medical devices and health tech are proving attractive for Asia-Pacific family office investments.

Comments


bottom of page